VEGF blockade decreases the tumor uptake of systemic oncolytic herpes virus but enhances therapeutic efficacy when given after virotherapy.

Autor: Eshun, F. K.1, Currier, M. A.1, Gillespie, R. A.1, Fitzpatrick, J. L.1, Baird, W. H.1,2, Cripe, T. P.1 timothy.cripe@cchmc.org
Zdroj: Gene Therapy. Jul2010, Vol. 17 Issue 7, p922-929. 8p. 4 Graphs.
Databáze: Academic Search Ultimate